Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Nov 28, 2022
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Pre-Application Webinars for NCI Cancer Screening Research Network (CSRN): ACCrual, Enrollment, and Screening Sites Hub (RFA-CA-23-020); Statistics and Data Management Center (RFA-CA-23-021); and Coordinating and Communication Center (RFA-CA-23-022)
(NOT-CA-23-017)
National Cancer Institute
- Notice of Informational Webinar for PAR-23-030 "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32)"
(NOT-GM-23-026)
National Institute of General Medical Sciences
- Findings of Research Misconduct
(NOT-OD-23-024)
Office of the Director, NIH
- Request for Information (RFI): Priorities for Precision Cancer Prevention of Pancreatic and Liver Cancer Science at NCI
(NOT-CA-23-014)
National Cancer Institute
- Request for Information: Priorities for Cancer Prevention and Symptom Management Science at NCI
(NOT-CA-23-016)
National Cancer Institute
Notice of Changes to Funding Opportunities
- Notice of Correction to RFA-CA-22-050, NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)".
(NOT-CA-22-132)
National Cancer Institute
- Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-026 "Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)"
(NOT-GM-23-010)
National Institute of General Medical Sciences
- Clarification of Eligibility for Institutions with Multiple Campuses in PAR-22-220 "Postbaccalaureate Research Education Program (PREP) (R25 - Independent Clinical Trial Not Allowed)"
(NOT-GM-23-019)
National Institute of General Medical Sciences
- Notice of Change to the Key Dates for PAR-20-049 "NINDS Postdoctoral Mentored Career Development Award (K01 - No Independent Clinical Trial Allowed)"
(NOT-NS-23-044)
National Institute of Neurological Disorders and Stroke
- Notice of Change to the Key Dates for PAR-20-050 "NINDS Postdoctoral Mentored Career Development Award (K01 - Clinical Trial Required)"
(NOT-NS-23-045)
National Institute of Neurological Disorders and Stroke
- Notice of Correction to Eligibility Criteria for RFA-NS-22-011 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)"
(NOT-NS-23-047)
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
- Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
(NOT-AI-23-001)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
- Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine
(NOT-AI-23-007)
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): Administrative Supplements to Prepare Data Assets for Infectious and Immune-mediated Diseases for Inclusion into the NIAID Data Ecosystem
(NOT-AI-23-009)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of General Medical Sciences
- Notice of Special Interest (NOSI): Complement in Fundamental Immunology
(NOT-AI-23-012)
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): Advancing Research for Tickborne Diseases (TBDs)
(NOT-AI-23-013)
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
- Notice of Special Interest: Promoting Research Opportunities on HIV/AIDS in NIAMS
(NOT-AR-23-004)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Funding Opportunities
- Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
(PAR-22-256)
National Cancer Institute
- Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
(PAR-23-025)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
(PAR-23-026)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Testing Centers for Development of Somatic Cell Genome Editing in Model Organisms (U42) (Clinical Trials Not Allowed)
(PAR-23-038)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
(PAR-23-051)
National Cancer Institute
- Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
(PAR-23-052)
National Cancer Institute
- Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
(PAR-23-053)
National Institute on Aging
Office of Research on Women's Health
- Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
(PAR-23-054)
National Institute on Aging
Office of Research on Women's Health
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
(PAR-23-065)
National Institute of Allergy and Infectious Diseases
- International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)
(RFA-AI-22-067)
National Institute of Allergy and Infectious Diseases
- Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
(RFA-FD-23-012)
Food and Drug Administration
- Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
(RFA-HD-24-006)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
- Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional)
(RFA-MH-23-310)
National Institute of Mental Health
- Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
(RFA-RM-23-003)
Office of Strategic Coordination (Common Fund)
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail).